Stakeholders With Losses In Allarity Therapeutics, Inc. Are Invited To Contact The Schall Law Firm About A Securities Fraud LawsuitAccesswire • 1h
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!PRNewsWire • Thursday
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • Thursday
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Thursday
Allarity Therapeutics Inc May Have Defrauded The Public And The Schall Law Firm Seeks Investor Participation In A CaseAccesswire • Wednesday
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • Wednesday
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Wednesday
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • Wednesday
Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion.GlobeNewsWire • Tuesday
Stockholders With Losses In Allarity Therapeutics, Inc. Are Urged To Help The Schall Law Firm With A Lawsuit For Securities Law ViolationsAccesswire • Tuesday
Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • Tuesday
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • Tuesday
ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Tuesday
Allarity Therapeutics Inc May Have Defrauded The Public And The Schall Law Firm Seeks Shareholder Participation In A CaseAccesswire • Tuesday
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc.GlobeNewsWire • Monday
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • Monday
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmBusiness Wire • Monday
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. (ALLR)GlobeNewsWire • Monday
ALLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • Monday
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • Monday
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. Inc. of Class Action Lawsuit and Upcoming Deadlines – ALLRAccesswire • 09/15/24
Pomerantz Law Firm Announces the Filing of a Class Action Against Allarity Therapeutics, Inc. and Certain Officers - ALLRAccesswire • 09/13/24
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 09/13/24
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)GlobeNewsWire • 09/11/24
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities lawsPRNewsWire • 08/23/24